- Home
- CVSA vs OPCH Comparison
CVSA vs OPCH Comparison
Compare CVSA & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVSA | OPCH |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United States |
| Employees | 4996 | N/A |
| Industry | Other Consumer Services | Medical/Nursing Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.4B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | CVSA | OPCH |
|---|---|---|
| Price | $116.22 | $28.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $150.00 | $37.00 |
| AVG Volume (30 Days) | 248.0K | ★ 1.5M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | $9.66 | $7.21 |
| Revenue Next Year | $6.58 | $8.55 |
| P/E Ratio | ★ N/A | $22.29 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $96.08 | $24.24 |
| 52 Week High | $118.80 | $36.80 |
Technical Indicators
Market Signals| Indicator | CVSA | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 61.10 | 43.15 |
| Support Level | $110.97 | $27.48 |
| Resistance Level | $118.80 | $28.90 |
| Average True Range (ATR) | 3.42 | 0.84 |
| MACD | -0.59 | 0.23 |
| Stochastic Oscillator | 67.97 | 56.04 |
Price Performance
Historical ComparisonAbout CVSA Covista Inc. Common Shares
Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.